UPDATE 1-GSK pulls out of $20 bln race for Pfizer assets

LONDON, March 23 (Reuters) - GlaxoSmithKline has withdrawn from the race to buy Pfizer's consumer healthcare business, the British drugs company said on Friday, endangering an auction for an asset some said could fetch as much as $20 billion.